DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Protein Kinase TargetsProtein Kinase Targets
  5. /c-Kitc-Kit
  6. /Dasatinib MonohydrateDasatinib Monohydrate
Chemical structure of CAS 863127-77-9

Dasatinib Monohydrate

CAS No.863127-77-9
MDL No.MFCD08704581
MFC22H28ClN7O3S
MW506.00
InChI KeyXHXFZZNHDVTMLI-UHFFFAOYSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Dasatinib monohydrate is the monohydrate form of dasatinib. It is used to treat chronic, accelerated, or myeloid/lymphoid blast phase chronic myeloid leukemia. The name 'dasatinib' refers to both the monohydrate (USAN) and anhydrous form (INN). It functions as an antineoplastic agent and tyrosine kinase inhibitor, containing anhydrous dasatinib.

CAS No.863127-77-9
Product NameDasatinib Monohydrate

Biological Targets

ABL1·BCR

Associated Conditions

Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive·B-cell acute lymphoblastic leukemia
* The information provided here is compiled from public sources and is for reference only.

Documentation

Similar Products

  • Dasatinib

    CAS No.302962-49-8

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact